
Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week
During the upcoming Abu Dhabi Global Health Week (ADGHW), a global initiative aimed at advancing longevity science and precision medicine will be released, expected to set a new standard for international collaboration, innovation, and investment in next-gen medical technologies.
The initiative is designed to drive the widespread adoption of personalised healthcare approaches and promote research into extending healthy lifespans. This call to action comes at a pivotal moment, as global life expectancy has more than doubled to 71 years, yet the gap between healthspan and lifespan has widened to 9.6 years, meaning many people spend nearly a decade of their lives in poor health as a result of chronic diseases.
Speaking ahead of the event, H.E. Mansoor Ibrahim Al Mansoori, Chairman of DoH stated 'We are delivering personalised and preventive health solutions that empower people to live longer, healthier, and more fulfilling lives. Because health knows no boundaries, we are inviting the world to co-create the next era of health, underpinned by collaboration, driven by data and transformative technology such as AI. From Abu Dhabi to the world, we are building an intelligent, integrated health system that scales globally and serves locally.'
With world-class research institutions, strategic investments, and artificial intelligence (AI)-driven medical advancements, Abu Dhabi is transforming the healthcare industry by advancing research, enabling strategic global partnerships, and ensuring equitable access to healthy life-extending medical innovations. The emirate's focus on AI-powered medical research is enhancing disease prediction and precision therapeutics, further solidifying its position as a leader in healthcare innovation.
This global leadership is built on a foundation of concrete action. Abu Dhabi's commitment to healthy longevity is already translating into impact. The emirate recently licensed the Institute for Healthier Living Abu Dhabi (IHLAD) as the world's first Healthy Longevity Medicine Centre, offering AI-enabled, personalised care to extend healthy lifespan, manage chronic diseases, and support mental well-being and lifestyle transformation. This was followed by the launch of the Healthy Longevity Innovation Forum and the introduction of the region's first regulatory framework for longevity-focused medical centres—setting a new benchmark for healthcare governance. Together with initiatives like the Healthy Longevity Symposium hosted by the Khalifa University and a growing network of global research partnerships, these efforts firmly position Abu Dhabi at the forefront of reimagining how societies approach aging, prevention, and extended health spans. The initiative, developed with and for the world, will create a roadmap that advances AI-powered diagnostics, genomics-based healthcare, and personalised treatment strategies, ensuring more people can benefit from extended healthy lifespans.
Key highlights to expect:
Launch of a global consensus document on longevity and precision medicine
Commitments from international stakeholders to advance AI-driven healthcare solutions
Frameworks for integrating genomics-based approaches into mainstream medical practice
Policy recommendations and regulatory pathways to facilitate longevity innovation
Global strategies for ethical, equitable, and responsible medical advancements
The initiative will be a highlight of ADGHW, scheduled to take place from 15 – 17 April 2025. The three-day event provides a platform to exchange insights, address critical healthcare challenges, and build partnerships that drive meaningful progress in global health and well-being. The event is expected to attract more than 200 speakers, 15,000 visitors, 1,900 delegates and 150 exhibitors from 90 countries.
Further details regarding the initiative will be announced at ADGHW.
ADGHW is a major government initiative from DoH and serves as a platform for innovation and collaboration under the theme 'Towards Longevity: Redefining Health and Well-being.' It places a strong emphasis on community-driven health and well-being, with a proactive approach centred around preventive, personalised, and holistic care.
Four core themes will guide discussions and initiatives: Longevity and Precision Health; Health System Resilience & Sustainability; Digital Health & AI; and Investment in Life Sciences. By convening diverse stakeholders from around the world, ADGHW is a community without borders that seeks to advance the future of health and well-being.
About Abu Dhabi Global Health Week:
Abu Dhabi Global Health Week (ADGHW) is a major government-led initiative by the Department of Health – Abu Dhabi (DoH). It drives transformative innovation and collaboration under the theme 'Towards Longevity: Redefining Health and Well-being'. ADGHW serves as a year-round 'always-on' platform with a proactive approach centred around preventive, personalised, and holistic care. Held with and for the world, ADGHW is a platform for open, inclusive exchange, and joint action.
ADGHW welcomes entrepreneurs, policymakers, researchers, innovators, and investors to transform ideas into action, and collaborate around topics like advancing precision care and building a resilient technology-driven ecosystem. ADGHW 2025 proudly collaborates with key strategic partners, including Foundation Partner, M42 and Global Health and Longevity Champion, PureHealth. Additional exhibitors and sponsors include Burjeel, GSK, Johnson & Johnson, Lilly, Microsoft, Novo Nordisk, Viatris, Novartis, Roche, Cleveland Clinic Abu Dhabi, Deloitte, Gilead, Juvenescence, NYU Abu Dhabi and Pfizer, united in their commitment to advancing the future of healthcare and life sciences.
For more information on ADGHW, visit https://www.adghw.com/
For media registration visit, https://www.adghw.com/forms/media-registration/
For ADGHW media inquiries or interview opportunities, please contact:
Maroun Farah, Senior Media Relations Manager, Weber Shandwick
E: mfarah@webershandwick.com
About the Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforces standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system. For further information on DOH, visit https://www.doh.gov.ae/ and follow on Twitter, Instagram, Facebook, LinkedIn and YouTube.
For DoH media inquiries, please contact: Mariam Al Marzooqi
msalmarzooqi@doh.gov.ae,
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Al Etihad
2 hours ago
- Al Etihad
Abu Dhabi: Malaffi reaches 3.5 billion clinical records
14 Aug 2025 11:36 ABU DHABI (ALETIHAD) Malaffi, the region's first Health Information Exchange (HIE) platform and a strategic initiative of the Department of Health – Abu Dhabi (DoH), operated by M42's Abu Dhabi Health Data Services (ADHDS), has achieved a significant milestone by reaching 3.5 billion clinical records, representing 12.7 million unique patient profiles across Abu Dhabi to help progress the UAE's advance in precision and preventive care. The milestone highlights Malaffi's ongoing evolution as a cutting-edge Health Information Exchange platform that supports innovation and excellence in the delivery of healthcare services. Malaffi continues to improve healthcare professionals' access to and utilisation of critical patient information. With connections to nearly all healthcare facilities – including hospitals, clinics and pharmacies - in the Emirate, Malaffi now supports 53,476 authorised users, from doctors and nurses to allied health professionals across 3,072 healthcare facilities in Abu platform's latest enhancements expand its capabilities with the addition of over 160,000 M42 Pharmacogenomics Reports, offering personalised insights into patients' genetic responses to medications to optimise treatment plans. Furthermore, new diagnostic test results across key specialities—such as Mental Health, Ophthalmology, Otolaryngology, and Respiratory Diagnostics—provide clinicians with deeper insights to elevate patient advancements are complemented by features like the Radiology Image Exchange, allowing access to radiology images from over 60 facilities to all authorised clinical users, and the AI-powered Patient Risk Profile, which predicts risks for chronic conditions and acute events. Together, these innovations streamline workflows, enhance decision-making and support better healthcare Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said: 'Malaffi's access to 3.5 billion medical records marks a pivotal milestone, reflecting the Department of Health – Abu Dhabi's steadfast commitment to creating the world's most intelligent, patient-centric healthcare system." She added: "By harnessing innovative healthcare solutions powered by artificial intelligence, such as pharmacogenomics and predictive analytics, Malaffi continues to advance, enabling healthcare providers to deliver services that meet the highest standards of care and empower community members to lead healthier lives. This achievement further strengthens Abu Dhabi's position as a globally leading digital healthcare ecosystem.'Kareem Shaheen, CEO of M42's Digital Health Solutions platform, added: "This milestone is a testament to the collaborative efforts of Abu Dhabi's healthcare ecosystem and the visionary leadership of the Department of Health." He added: "Aligned with M42's mission to advance innovation in health for people, Malaffi is securely connecting critical patient information with clinicians to enable informed decision-making, elevate healthcare standards and deliver quality patient outcomes. With every new feature and service we introduce, we are revolutionising the way care is delivered, ensuring better outcomes for patients and providers alike." With 3.5 billion clinical records now connected, Malaffi plays a key role in enhancing Abu Dhabi's healthcare ecosystem and providing a strong foundation for research, from AI-driven analytics to advanced treatments. As Abu Dhabi progresses in its digital transformation, Malaffi supports the Emirate's growth by offering innovative solutions that benefit patients and providers, reinforcing its position as a global hub for healthcare innovation. Source: Aletihad - Abu Dhabi


Gulf Today
15 hours ago
- Gulf Today
Aunt's heroic donation saves nephew as UAE doctors perform youngest infant liver transplant
A five-month old 4.4-kilogramme Emirati boy, stricken with a rare unpreventable recessive X disorder, and the youngest recipient of a donated liver in the UAE, courtesy of his 37-year-old paternal aunt, shall now be on lifelong monitoring and treatment. Fifth child Ahmed Al Yassi is recuperating at the Burjeel Medical City-Paediatric Intensive Care Unit (BMC-PICU) since his April 4, 2025 12-hour ultra-delicate transplantation. His giant strength, and his family's and the medical team's indefatigability, serve as an inspiring testimony for the August 13 'World Organ Donation Day." The WODD 2025 theme is 'Answering the Call,' for the continuous correct information dissemination on the necessity to grant one's organ/s to save lives. In the UAE, since 2017, is the Ministry of Health and Prevention-spearheaded National Programme for Donation and Transplantation of Human Organs and Tissues-Hayat Programme. According to a press statement, quoting undersecretary, Dr. Mohammed Salim Al Olama, it has been boosted with advanced digital solutions and artificial intelligence that guarantees transparency and efficiency at every stage of organ donation and transplantation process. Its website as of 4:30 p.m. of August 13 had '37,298 registered donors.' From a press statement quoting Department of Health-Abu Dhabi undersecretary Dr. Noura Khamis Al Ghaithi, 1,380 transplantations, through the Hayat Programme, were carried out from 2017 to 2024. The 2024 were at 290: seven heart, 142 kidney, 117 liver, 22 lung, and two pancreas. Over at BMC, elated was Ahmed's father Yahya: 'My baby's recovery is nothing short of a miracle. We were once a family living in fear of losing another child due to a liver problem. I hope our story inspires others to come forward, to learn more, and consider becoming donors. You never know whose life might change.' Abdominal Transplant and Hepato-Pancreatic Biliary surgeon Dr. Johns Shaji Mathew confirmed that Ahmed shall receive 'lifetime monitoring and therapy that includes immunosuppressive medications to prevent organ rejection, while the transplant on Ahmed has resolved the liver-related complications.' 'Ahmed will be regularly supervised by liver and genetics specialists for ongoing evaluation,' added Mathew, among the multi-disciplinary team members, led by Burjeel Abdominal Multi-Organ Transplant Programme-Transplant Surgery director Dr. Gourab Sen. The other on-case Transplant Team were Anaesthesia Division chairperson Dr. Ramamurthy Baskaran and specialists Dr. George Jacob and Dr. Anshu S., and Paediatric Intensive Care Unit (PICU) consultant Dr. Kesava Ramakrishnan. Their advice: 'urgent transplantation.' Ahmed's health debilitated due to the rise of his liver enzymes immediately birth. His diagnostics demonstrated that he is afflicted with ATP6AP1-Congenital Disorder of Glycosylation (ATP6AP1-CDG). Instrumental were the 'family's conviction' and the bravery-cum-volunteerism of mother-of-five Haifaa, Yahya's sister-in-law, who passed all compatibility tests. She and Ahmed are A+ blood type. Mathew said: 'The family's conviction came from the fact that without a transplant, Ahmed's survival chances were extremely low. They already experienced the loss of an older son to similar complications, which made them determined not to lose another.' 'The doctors gave us new hope. My sister-in-law gave us life again,' said Yahya. The USA-headquartered public-private-supported Frontiers in Congenital Disorders of Glycosylation (FCDG) portal notes that ATP6AP1-CDG generally affects males at one every one million. Ahmed has so far become the 31st survivor. There are 30 in other countries. The oldest patient is age 67. ATP6AP1-CDG 'age onset' range from the mother's pregnancy to age two, notes the Orphanet Knowledge on Rare Diseases and Orphan Drugs. From the FCDG, patients 'may have variable degree of liver dysfunction and immunodeficiency with recurrent infections.' Impaired-ness include developmental delays; abnormal body movement; gastrointestinal, urinary and genital problems; congenital heart defects and blood syndromes. So far, the solution is 'liver transplantation which has been successful in patients with severe liver failure.' Mathew said decreased transmission would only be via 'genetic screening and pre-marital genetic counselling to identify carriers and inform reproductive decisions for families with a known history.' Ahmed's family history has 'his grandfather passed on in 2010 due to a liver disease.' From the BMC Transplant Team that encourages a well-informed community on organ donation and transplantation: 'Ahmed's survival underscores the transformative power of organ donation and the advanced capabilities we now have in the UAE to perform complex, high-stakes surgeries for even the tiniest patients. Liver transplantation is not just surgical procedure; it is a second chance at life for those with no other options.'


Al Etihad
3 days ago
- Al Etihad
Renowned orthopaedic experts bring advanced care to Abu Dhabi in August
11 Aug 2025 22:33 SAMIHAH ZAMAN (ABU DHABI)Patients looking for world-class orthopaedic care close to home can benefit from a duo of doctors headed to Abu Dhabi as part of the Department of Health – Abu Dhabi's (DoH) Visiting Physicians Munjed Al Muderis, a US-based consultant in orthopaedic surgery and Singapore-based Dr. Aymeric Lim, senior consultant of hand and reconstructive microsurgery, are seeing patients at two healthcare facilities in the capital, the DoH has announced. 'The DoH welcomes top-tier doctors from around the world to the Emirate during August, offering exceptions healthcare services through the Visiting Physicians Programme,' the authority announced. Dr. Munjed Al Muderis (L) and Dr. Aymeric Lim (R) Al Muderis practises at the St Mary Hosptial, Paley Institute at West Palm Beach, one of the largest centres in orthopaedics and limb lengthening in the United States. He specialises in limb lengthening, the treatment of diabetic feet, osseointegration for amputees, limb reconstruction, joint replacement, bone tumour treatment and paediatric orthopaedics. According to the DoH, he will see patients at the Burjeel Medical City between August 11 and part of the National University Hospital in Singapore, has 30 years of experience in micro hand surgeries, nerve surgery, tendon transfer, and the treatment of patients with severe crush or nerve injuries in the forearm. He will offer treatment services at the Sheikh Shakhbout Medical City between August 11 and DoH has urged patients and their families to directly contact the respective hospitals in order to book appointments. The authority's Visiting Physicians Programme – launched in 2021 with the aim of providing world-class care in Abu Dhabi – had enabled the treatment of over 3,200 patients in the emirate as of December 2024. Source: Aletihad - Abu Dhabi